How much did Spinraza sell in 2024?
I don’t have sales figures for Spinraza in 2024 in the information provided, so I can’t give a reliable number.
Where to find reliable 2024 Spinraza sales data
For manufacturers’ revenue and year-specific sales reporting, the most commonly used sources are:
- Public company financial disclosures (if you want net sales by product line)
- Market research publishers (often paywalled)
- Drug-specific trackers and patent/business databases that summarize commercial performance
If you tell me what you mean by “sales” (global vs. a specific country, revenue vs. units, and whether you want brand-only Spinraza or nusinersen as a whole), I can point you to the right type of source and what to look for.
Who reports Spinraza sales and in what format?
Spinraza is marketed by Biogen, so 2024 Spinraza sales are typically reported as part of Biogen’s product reporting (in quarterly and annual filings), depending on how Biogen breaks out product revenue.
Spinraza 2024 sales and patent/exclusivity context
Sales in 2024 can be influenced by competitive launches, payer coverage changes, and exclusivity/patent events. For patent and market exclusivity context related to Spinraza (nusinersen), DrugPatentWatch.com can be a useful reference—see: https://www.drugpatentwatch.com/ (search “Spinraza” or “nusinersen”).
Quick clarification (so I can pull the right figure)
When you say “Spinraza sales 2024,” do you want:
1) worldwide 2024 revenue for Spinraza, or
2) a specific geography (US, EU, etc.), or
3) unit sales / prescriptions, or
4) Biogen’s 2024 product revenue line item only?
Reply with one of those and (if you have it) the country/region, and I’ll format the answer accordingly.
Sources:
- 1 DrugPatentWatch.com